Bausch Health Companies (BHC) Depreciation & Amortization (CF) (2011 - 2026)

Bausch Health Companies has disclosed Depreciation & Amortization (CF) across 16 years of filings, most recently posting $281.0 million for Q2 2026.

• In Q2 2026, Depreciation & Amortization (CF) fell 8.47% year-over-year to $281.0 million; the TTM figure through Jun 2026 stood at $1.2 billion (down 5.56% YoY), while the FY2025 annual figure was $1.2 billion, down 4.66% from the prior year.
• Depreciation & Amortization (CF) came in at $281.0 million for Q2 2026 at Bausch Health Companies, down from $295.0 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $360.0 million in Q4 2022 to a low of $281.0 million in Q2 2026.
• Average Depreciation & Amortization (CF) over 5 years is $317.2 million, with a median of $316.5 million recorded in 2023.
• Year-over-year, Depreciation & Amortization (CF) slipped 14.11% in 2022 and climbed 6.98% in 2024.
• Over 5 years, Depreciation & Amortization (CF) stood at $360.0 million in 2022, then slipped by 8.61% to $329.0 million in 2023, then dropped by 6.69% to $307.0 million in 2024, then slipped by 5.54% to $290.0 million in 2025, then decreased by 3.1% to $281.0 million in 2026.
• Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $281.0 million in Q2 2026, $295.0 million in Q1 2026, and $290.0 million in Q4 2025.